11/7
10:19 am
ions
Rating for IONS
Low
Report
Rating for IONS
11/7
10:19 am
ions
Rating for IONS
Low
Report
Rating for IONS
11/7
08:36 am
ions
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $60.00 price target on the stock.
Medium
Report
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $60.00 price target on the stock.
11/7
05:18 am
ions
Rating for IONS
Low
Report
Rating for IONS
11/7
05:18 am
ions
Rating for IONS
Low
Report
Rating for IONS
10/9
01:05 pm
ions
Rating for IONS
Low
Report
Rating for IONS
10/9
01:05 pm
ions
Rating for IONS
Low
Report
Rating for IONS
9/26
11:04 am
ions
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $70.00 price target on the stock.
Low
Report
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $70.00 price target on the stock.
9/26
11:04 am
ions
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $70.00 price target on the stock.
Low
Report
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $70.00 price target on the stock.
9/26
10:21 am
ions
Rating for IONS
Low
Report
Rating for IONS
9/26
10:21 am
ions
Rating for IONS
Low
Report
Rating for IONS
8/26
10:45 am
ions
Rating for IONS
Low
Report
Rating for IONS